lifescore

New research. Clear implications. Sharper decisions about status, advantage and access. Evidence-led articles and open datasets.

[lifescore @lifescoreEdge]

Know your status. Build your edge. Expand your access.

lifescore is in development. Edge is live today: evidence-led articles on health, performance, relationships, careers and social status.

Start here: https://t.co/wg5jPb8iTW

[lifescore @lifescoreEdge]

@DoctorTro Training to failure twice a week is solid advice. Lean mass drops alongside fat during GLP-1 loss, but the best randomized comparison shows no excess lean share lost, and a DXA scan isn't muscle, strength or function. Long-term, that's still open.

https://t.co/KzQvnc1IqP

[lifescore @lifescoreEdge]

@FFT1776 That's the visible failure. The deeper one: across PubMed, compounded GLP-1s have only been given to 94 people in one study, whose authors drew salary support from the wellness chain the participants bought from. That's the study we walked through.

https://t.co/bQZQ2Kfbo9

[lifescore @lifescoreEdge]

@investseekers Those numbers are solid; the trials are close too: 13.6% weight loss on the tablet, 14.9% on the injection. But separate trials, not a head-to-head, and oral exposure varies more person to person. We compared what each trial measured.

https://t.co/MtrHSiPiR9

[lifescore @lifescoreEdge]

@MohammedAlo The useful distinction is not “muscle panic” versus “no problem.” Trials commonly report lean mass, not muscle quality, strength or function. Absolute lean-mass loss can coexist with a better lean-mass share after larger fat loss.

https://t.co/KzQvnc1IqP

[lifescore @lifescoreEdge]

@maxmarchione Animal anecdotes cannot establish human efficacy. Dogs may not know they received a peptide, but outcomes can still reflect natural recovery, concurrent care and observer expectations. BPC-157 still lacks reliable human clinical evidence.

https://t.co/cNCPyeRaJC

[lifescore @lifescoreEdge]

@jjh_lifts DXA adds useful context, but it does not show muscle preservation. In the 189-person, 36-week substudy, fat mass fell more than lean mass—yet lean mass still declined. Strength, function and sarcopenia were not measured.

https://t.co/Qmr6tR3itF

[lifescore @lifescoreEdge]

@lightsilver323 https://t.co/Yv0jAXt7RQ — Know your status. Build your edge. Expand your access.

The platform is in development. Edge is live today: evidence-led articles on health, performance, relationships, careers and social status.

https://t.co/MTizqig8yh

[lifescore @lifescoreEdge]

Do GLP-1 drugs cause disproportionate muscle loss?

Lean mass often falls. Fat usually falls more. But lean mass is not skeletal muscle, strength or function. Direct evidence remains thin.

Read the evidence: https://t.co/KzQvnc1IqP

#GLP1 #MuscleHealth

[lifescore @lifescoreEdge]

Oral and injected Wegovy use the same molecule. Separate trials do not prove they match.

25 mg oral: -13.6%
2.4 mg weekly injection: -14.9%

No direct obesity head-to-head tested equivalence.

Read the evidence: https://t.co/MtrHSiPiR9

#Semaglutide #GLP1

[CNBC's Fast Money @CNBCFastMoney]

Want to know what's behind the bitcoin surge? @BKBrianKelly breaks it down

[HubSpot @HubSpot]

Your email signature is valuable real estate -- make sure you're using it. Create yours here: https://t.co/NcFrHmcIGN

[Splinter is on Bluesky @splinter_news]

Hey @realDonaldTrump, here's the truth about your "Great Wall."

[lifescore @lifescoreEdge]

Over the past year, an entirely new building typology has materialized: that of the super-tall, impo https://t.co/bSW4NXp4Nz

[lifescore @lifescoreEdge]

Westside Tower - Skyline Living https://t.co/MRyl85Owa3

[lifescore @lifescoreEdge]

Im "Grand Tower" entstehen Premium-Wohnwelten, die keine Wünsche offen lassen. Diese 3-Zimmer-Wohnun https://t.co/TI4n3dcGPq

[lifescore @lifescoreEdge]

Eurozone races to restructure Greek banks as bail-in looms - http://t.co/6oTPHBjxon http://t.co/Cy9tKQPCsj via @FT

[lifescore @lifescoreEdge]

The Shape Of Apple’s New iPhones http://t.co/RG2Dpi2zBD

[lifescore @lifescoreEdge]

#Imperva's fast growing Incapsula Technology (DDoS protection, WAF, CDN) vs #Akamai $IMPV $AKAM - Great overview at http://t.co/Nd6uwfx5Q9

[lifescore @lifescoreEdge]

Amazon curtails development of consumer devices http://t.co/8akRqlbWEf via @WSJ